Envoy Medical (COCH) Stock Price, News & Analysis

Company Overview

Envoy Medical (NASDAQ:COCH) is a medical device company focused on non-invasive neuromodulation therapies for dysphagia, a swallowing disorder that affects patients following neurological events or due to degenerative conditions. The company’s lead technology delivers targeted electrical stimulation designed to strengthen the muscles and neural pathways involved in the swallowing process.

Envoy Medical’s flagship therapy has received regulatory clearance from the U.S. Food and Drug Administration and is being introduced through rehabilitation centers, speech-language pathology clinics and acute care hospitals. The company works closely with healthcare providers to integrate its device into patient care pathways, supporting therapy both in clinical environments and at home.

Headquartered in the Minneapolis–Saint Paul metropolitan area, Envoy Medical currently serves the U.S. market and is evaluating opportunities for expansion into select international regions. Its leadership team combines expertise in medical device development, rehabilitation sciences and commercial operations, backed by private financing aimed at advancing innovative therapies for neurological and musculoskeletal disorders.

Key Stats

• Today's Range: $0.67 to $0.71
• 50-Day Range: $0.61 to $0.90
• 52-Week Range: $0.36 to $1.91
• Volume: 75,852 shs
• Average Volume: 593,339 shs
• Market Capitalization: $53.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.00
• Consensus Rating: Hold

Envoy Medical Stock Analysis - MarketRank™

Envoy Medical scored higher than 44% of companies evaluated by MarketBeat, and ranked 556th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.7 / 5
• Analyst Rating: Hold

Consensus Rating

Envoy Medical has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on no strong buy ratings, 2 buy ratings, 1 hold rating, and 1 sell rating.

Upside Potential

Envoy Medical has a consensus price target of $6.00, representing about 760.8% upside from its current price of $0.70.

Amount of Analyst Coverage

Envoy Medical has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Envoy Medical is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Envoy Medical is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

1.81% of the float of Envoy Medical has been sold short.

Short Interest Ratio / Days to Cover

Envoy Medical has a short interest ratio ("days to cover") of 7.32.

Change versus previous month

Short interest in Envoy Medical has recently increased by 10.16%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Envoy Medical does not currently pay a dividend.

Dividend Growth

Envoy Medical does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Envoy Medical this week, compared to 2 articles on an average week.

Search Interest

Only 2 people have searched for COCH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.9 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

6 insiders have purchased shares of Envoy Medical in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $8,173,460.00 in company stock, which represents 15.2530% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, Envoy Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $8,173,460.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

7.10% of the stock of Envoy Medical is held by insiders.

Percentage Held by Institutions

8.59% of the stock of Envoy Medical is held by institutions.

COCH Stock Analysis - Frequently Asked Questions

How have COCH shares performed this year?

Envoy Medical's stock was trading at $0.6611 at the beginning of 2026. Since then, COCH stock has increased by 5.4% and is now trading at $0.6970.

How were Envoy Medical's earnings last quarter?

Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Monday, March, 23rd. The company reported ($0.26) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.02. The company earned $0.08 million during the quarter, compared to analysts' expectations of $0.03 million.

Who are Envoy Medical's major shareholders?

Top institutional shareholders of Envoy Medical include DSG Capital Advisors LLC (0.81%). Insiders that own company stock include Glen A Taylor, Charles Brynelsen, Mona Chetan Patel, Brent T Lucas, Robert Potashnick and Susan Kantor.
View institutional ownership trends.

How do I buy shares of Envoy Medical?

Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Envoy Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPENG (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO), CrowdStrike (CRWD) and JPMorgan Chase & Co. (JPM).

Company Calendar

• Last Earnings: 3/23/2026
• Today: 5/05/2026
• Next Earnings (Estimated): 5/07/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:COCH
• CIK: 1840877
• Web: www.envoymedical.com
• Phone: 877-900-3277
• Fax: N/A
• Employees: 34
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Envoy Medical: $6.00
• High Price Target: $9.50
• Low Price Target: $2.50
• Potential Upside/Downside: +760.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.25
• Research Coverage: 4 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.22)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.76 million
• Net Margins: -9,857.26%
• Pretax Margin: -9,857.26%
• Return on Equity: N/A
• Return on Assets: -256.65%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.54
• Quick Ratio: 0.41

Sales & Book Value

• Annual Sales: $241 thousand
• Price / Sales: 222.35
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.42) per share
• Price / Book: -1.66

Miscellaneous

• Outstanding Shares: 76,881,000
• Free Float: 71,422,000
• Market Cap: $53.59 million
• Optionable: Not Optionable
• Beta: 1.92